Evidence map›Paper›PMID 40124719›Full record

ArticleHemaSphere2025

Long-term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients.

Rita Tavarozzi, Simone Ferrero, Andrea Evangelista, Elisa Genuardi, Daniela Drandi, Michael Mian, Manuela Zanni, Federica Cavallo, Alice Di Rocco, Vittorio Stefoni and 21 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Rita TavarozziDepartment of Translational Medicine University of Eastern Piedmont Novara Italy.ORCID 0000-0003-3696-7806
Simone FerreroDepartment of Molecular Biotechnologies and Health Sciences University of Torino Turin Italy.
Andrea EvangelistaUnit of Cancer Epidemiology, CPO, AOU Città della Salute e della Scienza di Torino Turin Italy.
Elisa GenuardiDepartment of Molecular Biotechnologies and Health Sciences University of Torino Turin Italy.
Daniela DrandiDepartment of Molecular Biotechnologies and Health Sciences University of Torino Turin Italy.
Michael MianDepartment of Hematology and Center of Bone Marrow Transplantation Hospital of Bolzano Bolzano Italy.
Manuela ZanniSCDU of Hematology, AOU SS. Antonio e Biagio e Cesare Arrigo Alessandria Italy.
Federica CavalloDepartment of Molecular Biotechnologies and Health Sciences University of Torino Turin Italy.ORCID 0000-0003-2047-1099
Alice Di RoccoHematology Department of Translational and Precision Medicine Sapienza University of Rome Rome Italy.
Vittorio StefoniInstitute of Hematology "L. e A. Seràgnoli" University of Bologna Bologna Italy.
Chiara PaganiUOC Ematologia, Spedali Civili di Brescia Brescia Italy.
Alessandro ReUOC Ematologia, Spedali Civili di Brescia Brescia Italy.
Barbara BottoAOU Città della Salute e della Scienza di Torino Turin Italy.
Monica BalzarottiHematology Unit IRCCS Humanitas Research Hospital Rozzano Milan Italy.
Vittorio R ZilioliDivision of Hematology ASST Grande Ospedale Metropolitano Niguarda Milan Italy.ORCID https://orcid.org/0000-0001-6915-2246
Maria Gomes da SilvaDepartamento de Hematologia Instituto Portugues de Oncologia de Lisboa Lisbon Portugal.
Luca ArcainiDepartment of Molecular Medicine University of Pavia Pavia Italy.
Anna L MolinariUnità Operativa di Ematologia Ospedale degli Infermi di Rimini Rimini Italy.
Filippo BalleriniIRCCS-Ospedale Policlinico San Martino Genoa Italy.
Andrés J M FerreriUnità Linfomi, IRCCS Ospedale San Raffaele Milan Italy.
Benedetta PucciniSOD Ematologia AOU Careggi Florence Italy.
Carlo ViscoDepartment of Medicine Section of Hematology University of Verona Verona Italy.
Piero M StefaniHematology Unit, General Hospital Treviso Treviso Italy.
Mario LuppiDepartment of Medical and Surgical Sciences UNIMORE Modena Italy.
Ivana CasaroliIRCCS San Gerardo Monza Italy.
Caterina StelitanoAzienda Ospedaliera Bianchi-Melacrino-Morelli Reggio Calabria Italy.
Giovannino CicconeUnit of Cancer Epidemiology, CPO, AOU Città della Salute e della Scienza di Torino Turin Italy.
Umberto VitoloFondazione del Piemonte per l'Oncologia-IRCCS, Candiolo Cancer Institute Candiolo Italy.
Maurizio MartelliDepartment of Hematology and Center of Bone Marrow Transplantation Hospital of Bolzano Bolzano Italy.
Sergio CortelazzoOspedale Centrale di Bolzano Bolzano Italy.
Marco LadettoDepartment of Translational Medicine University of Eastern Piedmont Novara Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40124719
PMCPMC11928766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.